Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 155.65 |
|---|---|
| High | 156.80 |
| Low | 148.00 |
| Bid | -- |
| Offer | -- |
| Previous close | 159.55 |
| Average volume | 385.30 |
|---|---|
| Shares outstanding | 164.38m |
| Free float | 150.41m |
| P/E (TTM) | 36.37 |
| Market cap | 30.74bn USD |
| EPS (TTM) | 5.14 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 16:35 GMT.
More ▼
Press releases
- Veeva to Release Fiscal 2026 Fourth Quarter and Full Year Results on March 4, 2026
- 13 of the Top 20 Biopharmas Standardize Globally on Veeva Link Key People
- 13 of the Top 20 Biopharmas Standardize Globally on Veeva Link Key People
- Veeva Announces eSource Application for Research Sites to Eliminate Paper and Streamline Clinical Trial Data Flow
- Veeva Announces eSource Application for Research Sites to Eliminate Paper and Streamline Clinical Trial Data Flow
- Industry Research Finds Establishing a Foundation for AI is Top Priority for CPG Enterprises
- Industry Research Finds Establishing a Foundation for AI is Top Priority for CPG Enterprises
- Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
- Veeva and BioMarin Form Long-Term Strategic Partnership
- Veeva and BioMarin Form Long-Term Strategic Partnership
More ▼
